Clinical trial
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In…
NCT00242710 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00242710 |
|---|---|
| Title | Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women |
| Official title | A Double-Blind, Randomized, Placebo- And Active-Controlled Efficacy And Safety Study Of Bazedoxifene/Conjugated Estrogens Combinations For Prevention Of Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometrial Hyperplasia, Osteoporosis |
| Intervention type | Drug, Other |
| Interventions | Bazedoxifene/Conjugated Estrogen, CE 0.45 mg/MPA 1.5mg, Placebo |
| Enrollment | 1,083 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Oct 20, 2005 |
| Last update posted | Dec 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: